Alzheimer's Disease Research Center
Search All News
The goal of the ADRC HS Scholars Program is to reach talented young people from backgrounds underrepresented in science and medicine, and to encourage and inspire them toward careers in these fields.
Many people live years or even decades with dementia, which causes death. Researching the symptoms and causes can dramatically help dementia care and prevention.
Dr. James M. Noble is an associate professor of neurology and dementia specialist in the Division of Aging and Dementia.
Research from Scott Small's lab at Columbia University suggests a different approach to tackling the disease, and a new startup company is now trying to turn that approach into treatments.
- May 22, 2022
Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease.
- April 28, 2022
A recent look inside a baby zebrafish's transparent brain offers clues to how we remember and how we forget.
- December 28, 2021
Columbia research seven years in the making highlights potential therapeutic target for neurodegenerative disease
- July 8, 2021
There is a robust market for books that praise our seemingly feeble habits of mind.
- June 28, 2021
The federal health insurance program may limit who can get the drug, which Biogen priced at $56,000 a year, to limit the financial impact
- June 8, 2021
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
- June 7, 2021
After exercising, choose a brain-healthy recovery meal.
- June 4, 2021
Other researchers are not convinced that these biomarkers vary by race, primarily because so little Alzheimer’s research has been conducted on Black and Latinx people.
Source:ForbesMay 21, 2021
It is well established that people who had fewer opportunities to receive education when they were children are at higher risk for Alzheimer’s disease later in life, noted Dr. Jennifer Manly
Source:CUIMC NewsroomMarch 30, 2021
A new study on COVID-19 patients with dementia led by James Noble, MD, MS associate professor of neurology at CUIMC